Labcorp Holdings Inc. (LH) income statement
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$370.78+2.54 (+0.69%)
Close on Nov 18, 2026Market cap $30.11BP/E 30.4Yield 0.78%
Labcorp Holdings Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 29.0%
- Operating margin
- 10.3%
- Net margin
- 6.9%
- Return on equity, FY2025
- 10.5%
Financial strength
- Current ratio
- 1.41
- Debt to equity
- 0.66
- Debt to assets
- 30.9%
- Cash to current liabilities
- 9.3%
Valuation
- P/E ratio
- 30.4
- Price to sales
- 2.06
- Price to book
- 3.40
- Dividend yield
- 0.78%
See a number that looks wrong?